Ayala Pharmaceuticals, Inc. — Form D

Ayala Pharmaceuticals, Inc. of MONMOUTH JUNCTION, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-02. The offering totals $434K, of which $434K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Roni A AppelDirectorMONMOUTH JUNCTION, NJ
Ken A BerlinDirectorMonmouth Junction, NJ
Vered A Bisker-LeibDirectorMONMOUTH JUNCTION, NJ
Yuval A CabillyDirectorMONMOUTH JUNCTION, NJ
Murray A GoldbergDirectorMONMOUTH JUNCTION, NJ
Bridget A MartellDirectorMONMOUTH JUNCTION, NJ
Pini A OrbachDirectorMONMOUTH JUNCTION, NJ
David A SidranskyDirectorMONMOUTH JUNCTION, NJ
Robert A SpiegelDirectorMONMOUTH JUNCTION, NJ
Ken A BerlinExecutive OfficerMonmouth Junction, NJ
Igor A GitelmanExecutive OfficerMONMOUTH JUNCTION, NJ
Roy A GolanExecutive OfficerMONMOUTH JUNCTION, NJ
Andres A GutierrezExecutive OfficerMONMOUTH JUNCTION, NJ
Thomas MooreDirectorFranklin, TN
Thomas MooreExecutive OfficerFranklin, TN
Richard BermanDirectorMerritt Island, FL
Mark J RosenblumExecutive OfficerHouston, TX
David SidranskyDirectorGermantown, MD
Kenneth BerlinDirectorMonmouth Junction, NJ
Kenneth BerlinExecutive OfficerMonmouth Junction, NJ
Samir KhleifDirectorMonmouth Junction, NJ
Igor GitelmanDirectorMonmouth Junction, NJ
Igor GitelmanExecutive OfficerMonmouth Junction, NJ
Roni AppelDirectorMonmouth Junction, NJ
James PattonDirectorMonmouth Junction, NJ

Other filings by this issuer (13)

FiledFormOfferingSold
2022-02-11D$4.8M$4.8M
2021-04-28D$11.1M$11.1M
2012-12-13D$10.0M
2012-06-06D$715K
2012-05-29D$4.5M
2012-02-24D$1.0M
2011-11-15D$2.0M
2011-05-27D$6.0M
2010-11-15D$835K
2010-07-30D$7.5M$7.5M
2009-10-22D$50K
2009-10-05D$5.0M$5.0M
2009-10-01D$962K

More